Streetbeat News

Price Targets

SIBN

SI-BONE (NASDAQ:SIBN) has received 8 bullish ratings from analysts in the last quarter, with no bearish or indifferent ratings. The average 12-month price target for the company is $29.75, an increase of 18.34% from the previous average of $25.14.

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 2:00 pm

ZBH

Truist Securities analyst Richard Newitter maintains a 'Hold' rating on Zimmer Biomet Holdings (NYSE:ZBH) and raises the price target from $147 to $153.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 2:00 pm

BAC

Morgan Stanley analyst Betsy Graseck maintains an Equal-Weight rating on Bank of America (NYSE:BAC) and raises the price target from $33 to $34.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 1:59 pm

VCEL

Truist Securities analyst Samuel Brodovsky maintains a 'Hold' rating on Vericel (NASDAQ:VCEL) and raises the price target from $36 to $42.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:58 pm

ICAD

Lake Street analyst Frank Takkinen maintains a 'Buy' rating on icad (NASDAQ:ICAD) and has raised the price target from $2.5 to $5.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:56 pm

AVB

Morgan Stanley analyst Adam Kramer has maintained an Equal-Weight rating on AvalonBay Communities (NYSE:AVB) and raised the price target from $180.5 to $194.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 1:56 pm

SYK

Truist Securities analyst Richard Newitter maintains a 'Hold' rating on Stryker (NYSE:SYK) and raises the price target from $300 to $310.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:55 pm

SIBN

Truist Securities analyst David Rescott maintains a 'Buy' rating on SI-BONE (NASDAQ:SIBN) and raises the price target from $28 to $33.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:54 pm

PEN

Truist Securities analyst David Rescott maintains a 'Buy' rating on Penumbra (NYSE:PEN) and raises the price target from $350 to $370.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:53 pm

NUVA

Truist Securities analyst Richard Newitter maintains a 'Hold' rating on NuVasive (NASDAQ:NUVA) and raises the price target from $48 to $51.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:51 pm